Investment Partners Asset Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Investment Partners Asset Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$447K	Hold	4,085	–	–	0.25%	106
2026 Q1	$424K	Hold	4,085	–	–	0.26%	105
2025 Q4	$421K	Sell	4,085 -40	-1%	-$3.89K	0.26%	103
2025 Q3	$373K	Sell	4,125 -94	-2%	-$8.23K	0.25%	116
2025 Q2	$371K	Sell	4,219 -12	-0.3%	-$1.04K	0.26%	114
2025 Q1	$386K	Sell	4,231 -75	-2%	-$6.75K	0.3%	101
2024 Q4	$372K	Sell	4,306 -20	-0.5%	-$1.81K	0.29%	103
2024 Q3	$411K	Sell	4,326 -10	-0.2%	-$950	0.34%	94
2024 Q2	$397K	Sell	4,336 -20	-0.5%	-$1.78K	0.35%	84
2024 Q1	$395K	Hold	4,356	–	–	0.36%	88
2023 Q4	$354K	Buy	+4,356	New	+$342K	0.35%	87

Other funds holding PPH

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

RBC

Rye Brook Capital Greenwich, Connecticut $143M AUM 33.65% 1-Year Est. Return

WWM

WT Wealth Management Scottsdale, Arizona $361M AUM 23.03% 1-Year Est. Return

Fluent Financial Dallas, Texas $280M AUM 16.1% 1-Year Est. Return

AWMT

AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return

CWRP

Cassady Wealth & Retirement Planning Henderson, Nevada $215M AUM

AWM

Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return

AWA

ARQ Wealth Advisors Scottsdale, Arizona $807M AUM 19.58% 1-Year Est. Return

AWM

Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return

Warner Financial Bethesda, Maryland $340M AUM 22.81% 1-Year Est. Return

Investment Partners Asset Management's PPH Position: Q2 2026 in Review

Investment Partners Asset Management held its VanEck Pharmaceutical ETF (PPH) position steady in Q2 2026 at 4,085 shares worth $447K. The position accounts for 0.25% of the portfolio, ranked #106.

Investment Partners Asset Management first reported a position in PPH in Q4 2023 and has held it in 11 quarters since. 39 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Investment Partners Asset Management held 4,085 shares of VanEck Pharmaceutical ETF worth $447K as of Q2 2026.
Investment Partners Asset Management left its VanEck Pharmaceutical ETF share count unchanged in Q2 2026.
VanEck Pharmaceutical ETF made up 0.25% of Investment Partners Asset Management's portfolio in Q2 2026, its #106 holding.
Investment Partners Asset Management first reported a position in VanEck Pharmaceutical ETF in Q4 2023 and has held it in 11 quarters since.
39 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Investment Partners Asset Management's 13F filing for Q2 2026, filed 24 Jul 2026.